The Arab Drug Company (EGX:ADCI)
Egypt · Delayed Price · Currency is EGP 216.00
+4.85 (2.30%)
At close: Jun 4, 2026
The Arab Drug Company Ratios and Metrics
Market cap in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 3, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 2,592 | 1,209 | 482 | 401 | 275 | 397 | |
Market Cap Growth | 149.61% | 150.60% | 20.27% | 45.83% | -30.70% | 12.18% |
Enterprise Value | 3,069 | 1,638 | 766 | 505 | 302 | 355 |
Last Close Price | 216.00 | 97.36 | 36.05 | 27.93 | 17.42 | 22.93 |
PE Ratio | 11.32 | 6.08 | 5.46 | 5.64 | 3.61 | 3.91 |
Forward PE | - | 8.58 | 8.58 | 8.58 | 8.58 | 8.58 |
PS Ratio | 1.95 | 1.08 | 0.61 | 0.63 | 0.55 | 0.74 |
PB Ratio | 3.76 | 1.95 | 1.05 | 1.05 | 0.81 | 1.28 |
P/TBV Ratio | 3.76 | 1.95 | 1.05 | 1.05 | 0.81 | 1.28 |
P/FCF Ratio | 24.83 | - | - | 16.49 | - | 51.48 |
P/OCF Ratio | 10.96 | 7.36 | 3.55 | 4.58 | 8.37 | 10.85 |
EV/Sales Ratio | 2.31 | 1.47 | 0.98 | 0.80 | 0.60 | 0.66 |
EV/EBITDA Ratio | 0.12 | 0.06 | 6.35 | 5.08 | 3.01 | 2.73 |
EV/EBIT Ratio | 8.30 | 5.25 | 6.48 | 5.21 | 3.32 | 2.90 |
EV/FCF Ratio | 29.39 | - | - | 20.77 | - | 46.03 |
Debt / Equity Ratio | 0.88 | 0.83 | 1.13 | 0.50 | 0.44 | 0.07 |
Debt / EBITDA Ratio | 0.02 | 0.02 | 4.26 | 1.91 | 1.51 | 0.16 |
Debt / FCF Ratio | 6.12 | - | - | 7.90 | - | 2.75 |
Net Debt / Equity Ratio | 0.74 | 0.70 | 0.62 | 0.37 | 0.33 | -0.13 |
Net Debt / EBITDA Ratio | 0.02 | 0.02 | 2.36 | 1.42 | 1.11 | -0.30 |
Net Debt / FCF Ratio | 5.13 | -12.50 | -1.89 | 5.82 | -1.94 | -5.07 |
Asset Turnover | 0.93 | 0.91 | 0.87 | 1.01 | 0.99 | 1.31 |
Inventory Turnover | 2.45 | 2.31 | 2.12 | 1.71 | 1.61 | 1.85 |
Quick Ratio | 0.48 | 0.63 | 1.01 | 0.73 | 0.68 | 0.80 |
Current Ratio | 1.31 | 1.52 | 1.93 | 2.49 | 2.31 | 2.75 |
Return on Equity (ROE) | 45.48% | 42.26% | 24.43% | 22.88% | 23.48% | 36.32% |
Return on Assets (ROA) | 17.27% | 15.87% | 8.13% | 9.66% | 11.12% | 18.67% |
Return on Invested Capital (ROIC) | 27.48% | 26.85% | 14.45% | 15.43% | 19.53% | 41.14% |
Return on Capital Employed (ROCE) | 42.60% | 36.00% | 15.00% | 19.80% | 23.10% | 39.50% |
Earnings Yield | 9.80% | 18.85% | 21.32% | 20.64% | 27.74% | 25.55% |
FCF Yield | 4.03% | -2.86% | -31.14% | 6.07% | -20.74% | 1.94% |
Dividend Yield | 1.93% | 4.28% | 11.58% | 8.06% | 13.78% | 10.90% |
Payout Ratio | 41.48% | 27.70% | 35.11% | 45.29% | 57.06% | 38.31% |
Buyback Yield / Dilution | - | - | - | 11.45% | 2.11% | 6.76% |
Total Shareholder Return | 1.97% | 4.28% | 11.58% | 19.51% | 15.89% | 17.66% |